A history of the term "DMARD"

被引:25
|
作者
Buer, Jonas Kure [1 ]
机构
[1] Univ Oslo, Dept Social Anthropol, N-0317 Oslo, Norway
关键词
DMARD; SAARD; RID; DC-ART; Drug classes; Rheumatology; History; Anthropology; ACTING ANTIRHEUMATIC DRUGS; REMISSION-INDUCING DRUGS; DISEASE-MODIFYING DRUGS; RHEUMATOID-ARTHRITIS; CLASSIFICATION; THERAPY; SAARDS; AZATHIOPRINE; COMBINATION;
D O I
10.1007/s10787-015-0232-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The article outlines a history of the concept of "disease-modifying antirheumatic drugs" or DMARDs-from the emergence in the 1970s of the idea of drugs with decisive long-term effects on bone erosion in rheumatoid arthritis (RA), through the consolidation and popularisation in the term DMARD in 1980s and 1990s. It then examines the usage of the terms "remission-inducing drugs" (RIDs) and "slow-acting anti-rheumatic drugs" (SAARDs), which for some years offered competition to the term DMARDs, thus underscoring the contingency of the establishment of DMARD as a word. Finally, it juxtaposes the apparently spontaneous emergence of the three terms DMARD, SAARD and RID, and the disappearance of the latter two, with a failed attempt in the early 1990s to replace these terms with the new term "disease-controlling antirheumatic treatment" (DC-ART). The analysis highlights the paradoxical qualities of the DMARD concept as robust albeit tension ridden, while playing down the role of identified individuals and overarching explanations of purpose.
引用
收藏
页码:163 / 171
页数:9
相关论文
共 50 条
  • [1] A history of the term “DMARD”
    Jonas Kure Buer
    Inflammopharmacology, 2015, 23 : 163 - 171
  • [2] Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate
    O'Dell, JR
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : S53 - S58
  • [3] Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis
    Verstappen, M.
    Niemantsverdriet, E.
    Matthijssen, X. M. E.
    le Cessie, S.
    van der Helm-van Mil, A. H. M.
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [4] Combination DMARD therapy including corticosteroids in early rheumatoid arthritis
    Möttönen, TT
    Hannonen, PJ
    Boers, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : S59 - S65
  • [5] To stop the erosion of hope: the DMARD category and the place of semantics in modern rheumatology
    Jonas Kure Buer
    Inflammopharmacology, 2017, 25 : 185 - 190
  • [6] To stop the erosion of hope: the DMARD category and the place of semantics in modern rheumatology
    Buer, Jonas Kure
    INFLAMMOPHARMACOLOGY, 2017, 25 (02) : 185 - 190
  • [7] Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use
    Takahashi, Nobunori
    Fujibayashi, Takayoshi
    Kida, Daihei
    Hirano, Yuji
    Kato, Takefumi
    Kato, Daizo
    Saito, Kiwamu
    Kaneko, Atsushi
    Yabe, Yuichiro
    Takagi, Hideki
    Oguchi, Takeshi
    Miyake, Hiroyuki
    Watanabe, Tsuyoshi
    Hayashi, Masatoshi
    Kanayama, Yasuhide
    Funahashi, Koji
    Hanabayashi, Masahiro
    Hirabara, Shinya
    Asai, Shuji
    Takemoto, Toki
    Terabe, Kenya
    Asai, Nobuyuki
    Yoshioka, Yutaka
    Ishiguro, Naoki
    Kojima, Toshihisa
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (10) : 1707 - 1716
  • [8] Analysis of the reasons for DMARD therapy discontinuation in patients with rheumatoid arthritis in the Czech and Slovak republics
    Pavelka, K
    Forejtová, S
    Pavelková, A
    Zvárová, J
    Rovensky, J
    Tuchynová, A
    CLINICAL RHEUMATOLOGY, 2002, 21 (03) : 220 - 226
  • [9] Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study
    Bitossi, Alice
    Bettiol, Alessandra
    Silvestri, Elena
    Di Scala, Gerardo
    Bacherini, Daniela
    Lopalco, Giuseppe
    Venerito, Vincenzo
    Iannone, Florenzo
    Vitale, Antonio
    Tosi, Gian Marco
    Prisco, Domenico
    Rizzo, Stanislao
    Fabiani, Claudia
    Cantarini, Luca
    Virgili, Gianni
    Vannozzi, Lorenzo
    Emmi, Giacomo
    MEDIATORS OF INFLAMMATION, 2019, 2019
  • [10] How do the biologics fit into the current DMARD armamentarium?
    Kalden, JR
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 27 - 35